Dr David Hughes has been appointed to the board of directors, effective immediately. He will also continue with his responsibility for overseeing
CN Bio Innovations features in Al Jazeera documentary “The Cure”
Welwyn Garden City, UK, 11 August 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms, was featured in the 10 August
CN Bio Innovations announces deal with sixth pharmaceutical collaborator in 2015 and features in The Economist
Welwyn Garden City, UK, 12 June 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics for
CN Bio Innovations announces LiverChip research study with leading pharmaceutical company
Welwyn Garden City, UK, 27th May 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics
CN Bio Innovations announces Hepatitis B research collaboration with leading pharmaceutical company
Welwyn Garden City, UK, 21st April 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics
CN Bio announces research collaboration with antisense discovery pioneers Isis Pharmaceuticals
CN Bio Innovations, an expert in developing human biomimetic platforms to test and develop therapeutics for liver diseases and infection, is pleased
CN Bio hosts popular Investigator Meeting and presents new HBV data at AASLD 2014
CN Bio Innovations’ (CN Bio) Investigator Meeting entitled “Hepatitis B: New models pave the way to a cure” was held on Monday 10th November 2014 at
NIH Director highlights LiverChip in Compton Lecture
Dr Francis S. Collins, Director of the US National Institutes of Health (NIH), highlighted LiverChip during the 2014 Karl Taylor Compton Lecture on
TSB Funds New Research by CN Bio into Fatty Liver Disease
CN Bio Innovations (CN Bio) announced today the receipt of a 12 months funding award from the UK’s Technology Strategy Board (TSB) for the development